1,3,4Department of Biochemistry, School of Life Sciences, Federal University of Technology, Minna, Nigeria.
2Department of Biotechnology, Faculty of Sciences, Mewar International University, Masaka, Nigeria.
5Department of Biochemistry, Faculty of Natural and Applied Sciences, Umar Musa Yar’adua University, Kastina, Nigeria
Body weight serves as a key marker for assessing drug effects and potential toxicity. In this study, extract-treated rats exhibited no significant changes in body weight, indicating the absence of phytochemicals that influence weight. Additionally, the antioxidant properties of Spondias mombin extracts were analyzed, revealing a significant increase in superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH) activity, along with a reduction in malondialdehyde (MDA) levels, demonstrating potent antioxidant effects. The anti-inflammatory potential was evaluated using the egg albumin-induced paw edema model, where the 400 mg/kg extract dose exhibited greater inhibition compared to diclofenac. This suggests additional anti-inflammatory mechanisms, possibly involving antioxidant and membrane-stabilizing effects. Liver function tests showed that extract administration reduced ALT, AST, and ALP levels, demonstrating hepatoprotective potential. Similarly, renal function markers improved, with reduced urea and uric acid levels at higher extract concentrations, likely due to antioxidative and nephroprotective properties. Electrolyte balance was also positively influenced by extract treatment. These findings highlight the therapeutic potential of Spondias mombin extracts in modulating oxidative stress, inflammation, and organ function, supporting its traditional medicinal applications.
Medicinal plants have long been utilized for their therapeutic benefits, particularly in traditional medicine, where they serve as rich sources of bioactive compounds for disease treatment. Spondias mombin, commonly known as hog plum, has been traditionally used across various cultures to manage inflammatory conditions, gastrointestinal disorders, and microbial infections [1]. Its pharmacological effects are primarily linked to its diverse phytochemical composition, including flavonoids, tannins, alkaloids, and terpenoids, which exhibit strong antioxidant and anti-inflammatory properties [2]. Inflammation is a natural biological response to injury and infection; however, chronic or excessive inflammation contributes to the development of various diseases, such as arthritis, cardiovascular conditions, and liver dysfunction [3]. While non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac are commonly used to treat inflammation, prolonged use is associated with adverse effects, including gastrointestinal distress and liver toxicity [4]. As a result, there is growing interest in plant-based anti-inflammatory alternatives that offer therapeutic efficacy with fewer side effects. Oxidative stress is a major contributor to inflammatory and degenerative diseases, arising from an imbalance between reactive oxygen species (ROS) production and the body’s antioxidant defense mechanisms [5]. Key enzymatic antioxidants, including catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GSH), play a crucial role in mitigating oxidative damage by neutralizing free radicals [6]. Lipid peroxidation, marked by elevated malondialdehyde (MDA) levels, is a key indicator of oxidative stress-induced cellular damage. Plant-derived antioxidants have been reported to mitigate oxidative stress and enhance antioxidant enzyme activity, thereby protecting against inflammation-related tissue damage [7]. Given the traditional use of Spondias mombin in inflammation-related disorders, this study aimed to evaluate its anti-inflammatory, antioxidant, and hepatoprotective effects using an egg white-induced paw edema model in albino rats. Additionally, the impact of Spondias mombin extracts on liver and renal function markers was assessed to determine its potential toxicity or protective role in vital organs. The findings from this study contribute to the growing body of evidence supporting the pharmacological benefits of Spondias mombin and its potential as a natural alternative for managing inflammatory and oxidative stress-related diseases.
2.0MATERIALS AND METHODS
2.1Collection, Identification and Processing of Plant Fractions
An ethnobotanical survey guided the selection of Spondias mombin, a medicinal plant traditionally used by herbal practitioners in Niger State for managing inflammatory diseases. The plant leaves were collected from Gara village along Katcha Road in Katcha Local Government Area.
Dr. Grace E. Ugbabe, a specialist in Plant Taxonomy and Biosystematics at the National Institute for Pharmaceutical Research and Development (NIPRD), Idu, Abuja, identified the plant specimens. The authenticated samples were subsequently stored in the herbarium and assigned the voucher number NIPRD/H/7354. A total of 400 g of air-dried and coarsely ground plant material was subjected to methanol extraction for two hours using a Soxhlet apparatus. The resulting crude extract was obtained by evaporating the methanol to complete dryness under reduced pressure at 40 °C. A 20 g portion of the crude extract was dissolved in 250 mL of water and subsequently partitioned with equal volumes of n-hexane, chloroform, ethyl acetate, and water. The eluents were then evaporated to dryness under reduced pressure at 40 °C.
2.1Determination of Body Weight Changes
The experimental rats' body weights were recorded weekly by weighing each rat daily with a compact digital weighing scale (3000 g capacity, FEJ-3000B; China).
2.1In-vivo Antioxidant Assay
Forty-eight albino rats of mixed sex (n = 6 per group) were randomly divided into seven groups. Group I served as the control, while Groups II, III, IV, V, VI, and VII received oral doses of Spondias mombin chloroform and n-hexane solvent-partitioned extracts at 100, 200, and 400 mg/kg, respectively, for 14 days. On the final day, the animals were euthanized via cervical dislocation, and blood samples were collected into anticoagulant-free test tubes and left to clot at room temperature. Serum was separated by centrifugation at 3,000 rpm for 15 minutes using an electric desktop lab centrifuge (220V EU Plug, Jersey, UK). The obtained serum was transferred into anticoagulant-free test tubes using a micropipette and stored at 4°C for subsequent biochemical analyses.
2.1.1Lipid peroxidation assay
The thiobarbituric acid reactive substances (TBARS) assay was used to evaluate lipid peroxidation during an acid-heating reaction. Sample aliquots were mixed with 15% trichloroacetic acid and 0.38% thiobarbituric acid, then heated in a boiling water bath for one hour. The extent of lipid peroxidation was determined by measuring the absorbance of the pink-colored complex at 532 nm using a spectrophotometer, following the method outlined by Satoh [8].
2.1.2Superoxide dismutase assay
The assessment was conducted using a reaction mixture comprising 0.1 mL of phenazine methosulfate (186 µM) and 1.2 mL of sodium pyrophosphate buffer (0.052 M, pH 7.0). To this mixture, 0.3 mL of the supernatant—obtained through sequential centrifugation of the homogenate at 1,500 × g for 10 minutes, followed by 10,000 × g for 15 minutes—was added. The enzyme reaction was initiated by introducing 0.2 mL of NADH (780 µM) and terminated after one minute with the addition of 1 mL of glacial acetic acid. The resulting chromogen was quantified by measuring absorbance at 560 nm, with results expressed in units per milligram of protein, as described by Kakkar et al. [9].
2.1.3Catalase assay
The analysis was conducted using a reaction solution containing 2.5 mL of 0.05 M phosphate buffer (pH 8.3), 0.7 mL of 0.2 M hydrogen peroxide (H?O?), and 0.1 mL of tissue homogenate. The absorbance change at 570 nm was recorded after one minute. Results were expressed in units per milligram of protein, following the methodology outlined by Maehly and Chance [10].
2.1.4Reduced glutathione assay
The assessment was conducted using dithiobisnitrobenzoate as a substrate, generating a yellow-colored product. The absorbance was measured immediately at 412 nm, and the results were expressed as µM GSH per gram of protein, following the method described by Ellman [11].
2.2Anti-inflammatory Activity
The anti-inflammatory potential of chloroform and n-hexane solvent-partitioned extracts of Spondias mombin was assessed using the egg white-induced paw edema model [12,13]. The study utilized mixed-sex Wistar rats weighing between 150–200 g, which were housed in the animal facility of the School of Life Sciences, Federal University of Technology, Minna. The animals were maintained under controlled room temperature conditions with a natural day/night cycle, with access to food and water. The rats were randomly divided into nine groups, each consisting of six animals. They were fasted for one hour before the experiment. Group I was administered distilled water (5 mL/kg) as a blank control, while Group II received distilled water (5 mL/kg) as a negative control. Group III was treated with diclofenac (5 mg/kg) as a positive control. Groups IV, V, VI, VII, VIII, and IX received chloroform and n-hexane solvent-partitioned extracts of Spondias mombin at doses of 100, 200, and 400 mg/kg, respectively. One hour after administering the standard drug and plant extracts, the baseline paw diameter of each rat was measured using a caliper (0 h). Inflammation was induced in all groups except the neutral control by injecting 100 ?L of a 1% egg white solution intradermally into the left hind paw using a 1 mL syringe. Paw diameters were recorded at 1 h, 2 h, 4 h, 8 h, and 24 h post-injection. The extent of edema was determined by calculating the percentage increase in paw volume over time.
Increase?of?Paw?Volume (IPV)=
Paw? Volume at time T - Initial Paw?Volume Initial Paw?Volume
Percentage Inhibition = (IPV) control – (IPV) treated(IPV) control
2.3Data Analysis
All experiments were performed in triplicate, and the results were presented as mean ± standard error of the mean (SEM). Statistical analysis was conducted using one-way ANOVA in SPSS, followed by Dunnett’s post hoc test for comparisons with the control group. A p-value of less than 0.05 was considered statistically significant.
3.0RESULTS AND DISCUSSION
The effects of n-hexane and chloroform solvent-partitioned fractions of Spondias mombin on the body weight of animals are shown in Figure 1. The results indicate that the extracts did not adversely affect the weight gain of Wistar rats throughout the treatment period. Body weight increased progressively from week 1 to week 2.
3.1Effect of n-Hexane and Chloroform Solvent Partition Fractions of Spondias mombin on Serum Antioxidant enzymes
The findings of the serum antioxidant enzyme assays for n-hexane and chloroform solvent-partitioned extracts are summarized in Table 1. The activities of key antioxidant enzymes, including catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GSH), were significantly increased (P < 0>
Table 1: Effect of n-Hexane and Chloroform Solvent Partition Fractions of Spondias mombin on Serum Antioxidant enzymes
Group |
CAT (U/mg protein) |
SOD (U/mg protein) |
GSH (µg/mL) |
MDA (µM) |
Control |
4.75±0.16a |
9.00±0.18a |
55.09±0.13a |
34.10±0.14f |
H100 |
4.91±0.00a |
9.45±0.18a |
79.87±0.07d |
30.28±0.25e |
H200 |
7.98±0.20b |
17.14±0.12b |
80.18±0.15d |
27.13±0.11d |
H400 |
7.84±0.35b |
15.79±0.77b |
95.62±0.16f |
26.18±0.19c |
C100 |
5.56±0.07a |
10.15±0.07a |
64.78±0.25b |
26.21±0.38c |
C200 |
9.08±0.26c |
16.29±0.66b |
78.89±0.25c |
24.06±0.17a |
C400 |
10.11±0.47d |
20.35±0.63c |
86.46±0.24e |
25.51±0.10b |
Values are presented as mean ± standard error of mean (SEM) of three replicates. Values with different superscripts along column are significantly different at p < 0>
3.2Effect of n-Hexane and Chloroform partitioned Fractions of Spondias mombin on Egg Albumin-induced Paw Oedema in Rats
The impact of n-hexane and chloroform partitioned fractions of Spondias mombin on acute paw edema induced by egg albumin is summarized in Table 2. Injection of egg albumin caused a significant (P < 0>
Table 2: Effect of n-Hexane and Chloroform partitioned Fractions of Spondias mombin on Egg Albumin-induced Paw Oedema in Rats
|
Oedema volume (mm) |
|||||
Group |
0hr |
1hr |
2hr |
4hr |
8hr |
24hr |
Normal control |
0.44±0.02a |
0.44±0.02a |
0.44±0.02a |
0.44±0.02a |
0.44±0.02a |
0.44±0.02a |
Negative control |
0.43±0.02a |
1.05±0.03f |
1.16±0.03d |
1.07±0.03f |
0.87±0.03d |
0.80±0.04b |
Positive control |
0.42±0.02a |
0.91±0.01e |
0.72±0.02c |
0.56±0.01bcd |
0.43±0.02a |
0.42±0.02a |
H100 |
0.43±0.01a |
0.82±0.02bcd |
0.76±0.02c |
0.66±0.03e |
0.54±0.02c |
0.47±0.01a |
H200 |
0.43±0.02a |
0.77±0.03b |
0.63±0.01b |
0.56±0.01bcd |
0.46±0.02ab |
0.44±0.02a |
H400 |
0.44±0.02a |
0.80±0.03bc |
0.64±0.01b |
0.54±0.01bc |
0.47±0.01abc |
0.45±0.02a |
C100 |
0.43±0.02a |
0.90±0.05de |
0.75±0.04c |
0.62±0.03de |
0.51±0.04bc |
0.46±0.01a |
C200 |
0.44±0.02a |
0.88±0.04cde |
0.73±0.04c |
0.60±0.02cde |
0.51±0.03bc |
0.45±0.01a |
C400 |
0.42±0.02a |
0.86±0.02bcde |
0.63±0.01b |
0.52±0.01b |
0.43±0.01a |
0.42±0.02a |
Values are presented as mean ± standard error of mean (SEM) of three replicates. Values with different superscripts along column are significantly different at p < 0>
3.3Mean Percentage Inhibition of Egg Albumin-induced Paw Edema in Rats administered n-Hexane and Chloroform partitioned Fractions of Spondias mombin
The mean percentage inhibition of egg albumin-induced paw edema in rats treated with n-hexane and chloroform partitioned fractions of Spondias mombin is presented in Table 3. The highest inhibition, 42.65%, was observed in the group administered 400 mg/kg of the extract (C400) at 24 hours post-injection, whereas diclofenac exhibited a maximum inhibition of 39.40%.
Table 3: Mean Percentage Inhibition of Egg Albumin-induced Paw Oedema in Rats administered n-Hexane and Chloroform partitioned Fractions of Spondias mombin
|
% Inhibition at various times (hour) |
|||||
Treatment (mg/kg) |
1hr |
2hr |
4hr |
8hr |
24hr |
Mean of %Inhibition |
Positive control |
13.33 |
37.93 |
47.66 |
50.57 |
47.5 |
39.40 |
H100 |
21.91 |
45.69 |
38.32 |
37.93 |
41.25 |
37.02 |
H200 |
26.67 |
45.69 |
47.66 |
47.13 |
45.00 |
42.53 |
H400 |
23.81 |
44.83 |
49.53 |
45.98 |
43.75 |
41.58 |
C100 |
14.28 |
35.34 |
42.06 |
41.38 |
42.50 |
35.11 |
C200 |
16.19 |
37.07 |
43.93 |
41.40 |
43.75 |
36.47 |
C400 |
18.1 |
45.69 |
51.40 |
50.57 |
47.5 |
42.65 |
Values are presented as mean ± standard error of mean (SEM) of three replicates. Values with different superscripts along column are significantly different at p < 0>
3.4 Effect of n-Hexane and Chloroform Solvent Partitioned Fractions of Spondias mombin on ALT, AST and ALP
The impact of n-hexane and chloroform partitioned fractions of Spondias mombin on selected serum biochemical parameters is summarized in Table 4. Egg albumin injection led to a significant increase (p < 0>Spondias mombin n-hexane and chloroform fractions at doses of 100, 200, and 400 mg/kg significantly (p < 0>
Table 4: Effect of n-Hexane and Chloroform Solvent Partitioned Fraction of Spondias mombin on ALT, AST and ALP
Group |
ALT (U/L) |
AST (U/L) |
ALP (U/L) |
Normal control |
13.31±0.19a |
32.95±0.05e |
55.98±0.21d |
Negative control |
35.24±0.58h |
45.02±0.53h |
66.42±0.53f |
Positive control |
18.09±0.49de |
34.86±0.27f |
53.29±0.64c |
H100 |
20.21±0.20f |
28.97±0.12c |
53.81±0.35c |
H200 |
17.44±0.23cd |
27.74±0.17b |
49.09±0.21b |
H400 |
14.29±0.18b |
23.69±0.15a |
44.72±0.36a |
C100 |
23.60±0.21g |
35.70±0.14g |
59.00±0.38e |
C200 |
18.79±0.19e |
29.02±0.41c |
56.10±0.14d |
C400 |
16.90±0.24c |
30.07±0.21d |
49.04±0.23b |
Values are presented as mean ± standard error of mean (SEM) of three replicates. Values with different superscripts along column are significantly different at p < 0>
Key:
H= nHaxane
C= Chloroform
3.5 Effect of n-Hexane and Chloroform solvent partitioned Fraction of Spondias mombin on Total protein, Albumin and Bilirubin
Table 5 illustrates the effects of the n-hexane and chloroform solvent-partitioned fractions of Spondias mombin on total protein, albumin, and bilirubin levels. The negative control group showed a significant decrease (P < 0>
Table 5: Effect of n-Hexane and Chloroform solvent partitioned Fraction of Spondias mombin on Total protein, Albumin and Bilirubin
Group |
Total protein (g/L) |
Albumin (g/L) |
Bilirubin (mg/dL) |
Normal control |
10.61±0.22b |
7.72±0.15b |
0.85±0.03d |
Negative control |
8.00±0.29a |
5.73±0.23a |
0.99±0.01f |
Positive control |
13.29±0.21d |
9.72±0.28d |
0.61±0.01a |
H100 |
13.49±0.21d |
8.71±0.15c |
0.70±0.02b |
H200 |
16.28±0.27f |
9.83±0.28d |
0.77±0.01c |
H400 |
18.86±0.10g |
12.62±0.14e |
0.62±0.02a |
C100 |
11.63±0.18c |
8.66±0.12c |
0.83±0.02 |
C200 |
13.40±0.06d |
8.29±0.10c |
0.81±0.02 |
C400 |
15.19±0.17e |
9.99±0.08d |
0.91±0.02 |
Values are presented as mean ± standard error of mean (SEM) of three replicates. Values with different superscripts along column are significantly different at p < 0>
3.6Effect of n-Hexane and Chloroform Solvent Partitioned Fraction of Spondias mombin on Creatinine, Urea and Uric acid
Table 6 presents the effects of Spondias mombin n-hexane and chloroform solvent-partitioned fractions on creatinine, urea, and uric acid levels. Significant differences (P < 0>
Table 6: Effect of n-Hexane and Chloroform Solvent Partitioned Fraction of Spondias mombin on Creatinine, Urea and Uric acid
Group |
Creatinine (mg/dL) |
Urea (mg/dL) |
Uric acid (mg/dL) |
Normal control |
8.41±0.05b |
23.46±0.27cd |
5.71±0.10a |
Negative control |
12.73±0.31d |
32.70±0.27f |
9.04±0.40d |
Positive control |
7.49±0.25a |
26.02±0.53e |
6.53±0.23ab |
H100 |
9.33±0.31c |
22.12±0.21bc |
5.95±0.46a |
H200 |
8.46±0.18b |
24.44±0.40d |
6.46±0.22ab |
H400 |
9.33±0.06c |
23.19±0.14cd |
8.56±0.24cd |
C100 |
9.62±0.20c |
21.79±0.48b |
7.49±0.23bc |
C200 |
8.91±0.41bc |
20.02±0.57a |
7.53±0.70bc |
C400 |
8.54±0.13b |
21.36±0.76b |
5.72±0.24a |
Values are presented as mean ± standard error of mean (SEM) of three replicates. Values with different superscripts along column are significantly different at p < 0>
4.7Effect of n-Hexane and Chloroform Solvent Partitioned Fraction of Spondias mombin on Serum Electrolytes
Table 7 presents the effects of Spondias mombin n-hexane and chloroform solvent-partitioned fractions on serum electrolytes. The treated groups exhibited a significant (P < 0>
Table 7: Effect of n-Hexane and Chloroform Solvent Partitioned Fraction of Spondias mombin on Serum Electrolytes
Group |
Na (mEq/L) |
K (mEq/L) |
Cl (mEq/L) |
Normal control |
147.80±0.31e |
6.59±0.37c |
72.48±0.44c |
Negative control |
155.27±0.56g |
4.20±0.41a |
79.22±0.57e |
Positive control |
150.67±0.61f |
7.72±0.23d |
68.39±0.61a |
H100 |
142.55±0.40c |
6.59±0.16c |
70.42±0.56b |
H200 |
141.64±0.40c |
7.93±0.30de |
75.86±0.37d |
H400 |
136.92±0.25a |
5.39±0.16b |
67.79±0.32a |
C100 |
145.16±0.17d |
8.16±0.40de |
75.13±0.46d |
C200 |
142.58±0.41c |
8.64±0.13e |
78.93±0.42e |
C400 |
140.04±0.11b |
9.49±0.15f |
71.47±0.67bc |
Values are presented as mean ± standard error of mean (SEM) of three replicates. Values with different superscripts along column are significantly different at p < 0>
DISCUSSION
Body weight is a well-established indicator of drug effects and is frequently used to evaluate responses to drug therapy. Additionally, fluctuations in body weight can serve as early markers of toxicity [14]. In this study, no significant changes in body weight were observed in extract-treated rats. The gradual increase in body weight from week 1 to week 2 (Figure 1) among treated rats, compared to controls, suggests that the leaf extract lacks phytochemicals that influence body weight. This finding is consistent with Gupta et al. [15] but contrasts with the results of Odey et al. [16]. The overall weight gain observed in both control and treated groups reflects normal growth, aligning with prior research by Aroni et al. [17] on the effects of methanol extract of Albizia lebbeck leaves on rat body weight. The antioxidant defense system in animals includes key enzymes such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH), which neutralize reactive oxygen species (ROS) by converting them into less harmful molecules [5]. This study demonstrated a significant (P < 0>[6]. Elevated MDA levels in untreated control rats (Table 1) suggest an overwhelmed antioxidant defense system, leading to oxidative stress and progressive lipid peroxidation. However, MDA levels significantly decreased (P < 0>Spondias mombin n-hexane and chloroform fractions in the egg albumin-induced paw edema model. At 400 mg/kg (C400), the extract achieved a maximum inhibition of 42.65?ter 24 hours, surpassing diclofenac, which showed a 39.40% inhibition rate. Diclofenac, a widely used non-steroidal anti-inflammatory drug (NSAID), alleviates inflammation by inhibiting cyclooxygenase (COX) enzymes, thereby reducing prostaglandin synthesis [4]. The superior efficacy of the extract suggests additional anti-inflammatory mechanisms, possibly involving antioxidant, immunomodulatory, or membrane-stabilizing effects [3]. The egg albumin-induced paw edema model is a widely used method for assessing acute inflammation, involving mediators such as histamine, serotonin, kinins, and prostaglandins [17]. The observed reduction in edema suggests that the extract interferes with these inflammatory mediators. The anti-inflammatory activity of Spondias mombin is likely attributed to the presence of flavonoids, tannins, and triterpenoids, which are known for their anti-inflammatory properties [1]. Similar findings were reported by [2], who demonstrated the efficacy of hydroethanol extract (HELSM) of S. mombin in an oral mucositis model. Additionally, Silva et al. [18] found that chondroitin sulfate derived from Oreochromis niloticus waste significantly reduced leukocyte migration in a peritoneal inflammation model. Injection of egg albumin led to a significant (P < 0>[19,20]. However, administration of Spondias mombin extracts at 100, 200, and 400 mg/kg significantly reduced (P < 0>[7]. Similar results were reported by Calderon et al. [21], who demonstrated that Spondias mombin extracts did not alter serum ALT, AST, or ALP levels, suggesting the absence of hepatotoxicity. The hepatoprotective effect observed is likely due to the presence of antioxidants that mitigate oxidative stress and support liver function.
A significant decrease (P < 0>[22]. These markers indicate impaired hepatic synthesis and excretory function. Similar findings by Aboraya et al. [23] demonstrated that plant-based polyphenols restored protein and bilirubin levels in liver injury models. However, the reference drug showed superior efficacy, likely due to its targeted pharmacological action [24].
Significant differences (P < 0>[25,26]. However, treatment with 200 mg/kg of the n-hexane extract significantly reduced these levels, suggesting improved renal function, possibly through reduced oxidative stress or enhanced clearance. The chloroform extract at 400 mg/kg exhibited a similar effect, likely reflecting differences in the bioavailability of active compounds. The nephroprotective potential of Spondias mombin may be attributed to flavonoids, alkaloids, and tannins, which have antioxidative and anti-inflammatory properties [27]. These findings align with previous studies demonstrating the beneficial effects of polyphenol-rich extracts on renal dysfunction [28]. Electrolytes play essential roles in enzymatic activation, nutrient uptake, and hormonal balance [29]. The study revealed a dose-dependent effect of Spondias mombin extracts on electrolyte levels, with significant reductions at 200 mg/kg and 400 mg/kg doses compared to the positive control (Table 7). This suggests a regulatory effect on electrolyte homeostasis, potentially useful in managing electrolyte imbalances. The impact may result from phytochemicals influencing renal reabsorption or secretion processes [30]. Similar findings in phytotherapy indicate that plant extracts modulate renal and systemic electrolyte balance, as demonstrated by Ondua et al.[31], who reported that polyphenol-rich extracts reduced electrolyte imbalances in renal dysfunction models.
CONCLUSION
Overall, this study highlights the therapeutic potential of Spondias mombin extracts, particularly in their antioxidant, anti-inflammatory, hepatoprotective, nephroprotective, and electrolyte-modulating properties. These effects may be attributed to bioactive phytochemicals such as flavonoids, tannins, and saponins, which exert beneficial physiological actions.
Conflict of Interest
The authors declare no conflicts of interest.
Top of Form
Bottom of Form
ACKNOWLEDGMENTS
The authors express their gratitude to the Institutional-Based Research (IBR) Fund of the Federal University of Technology, Minna, Nigeria, for providing financial support.
REFERENCES
Umar Muazu*, Adamu Yusuf Kabiru, Maimuna Bello Umar, Ibrahim Hamza Kankia, Antioxidant, Anti-Inflammatory, and Liver-Protective Properties of n-Hexane and Chloroform Fractions of Spondias mombin Leaves in Albino Rats, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 2, 1419-1431. https://doi.org/10.5281/zenodo.14882541